Literature DB >> 19245590

Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis.

Wan-Tzu Chen1, Wen-Chun Hung, Wan-Yi Kang, Ya-Chun Huang, Yue-Chiu Su, Ching-Hsiu Yang, Chee-Yin Chai.   

Abstract

This study examines whether the expression of cyclooxgenase-2 (COX-2) in urothelial carcinoma (UC) is associated with macrophage infiltration, hypoxia-inducible factor-1alpha (HIF-1alpha) expression and angiogenesis. We investigated the expression of COX-2 associated with HIF-1alpha and performed double immunohistochemical analysis of 216 UCs for COX-2 expression and the correlation with tumor-associated-macrophage (TAM) density and microvessel density (MVD) in situ. A high expression of COX-2 was positively correlated with tumor invasiveness, histologic grade and HIF-1alpha expression in UC (p<0.0001, p=0.003, p<0.0001, respectively). Quantification of double staining of COX-2/CD34 and COX-2/CD68 showed that a higher MVD and TAM density was found in COX-2 high-expression than in COX-2 low-expression tumor fields (p<0.0001). Adjacent to the principal of COX-2 expression areas, MVD value and TAM density were significantly increased in HIF-1alpha high-expression specimens compared with HIF-1alpha low-expression ones (p<0.0001). Interestingly, our data revealed that high COX-2 expression (p=0.002), high HIF-1alpha expression (p<0.0001) and TAM density (p<0.0001) were all associated with high MVD value. Our results suggest that COX-2 may produce a cooperative effect in promoting tumor progression and may be involved in the process of angiogenesis through increasing TAM infiltration or HIF-1alpha regulation by hypoxia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19245590     DOI: 10.1111/j.1600-0463.2008.00004.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  10 in total

Review 1.  Stromal cells and integrins: conforming to the needs of the tumor microenvironment.

Authors:  Aimee Alphonso; Suresh K Alahari
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 2.  HIF-1 at the crossroads of hypoxia, inflammation, and cancer.

Authors:  Kuppusamy Balamurugan
Journal:  Int J Cancer       Date:  2015-04-07       Impact factor: 7.396

3.  Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification.

Authors:  Zhe Hou; Domenick J Falcone; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Carcinogenesis       Date:  2011-02-10       Impact factor: 4.944

4.  Increased COX-2 Immunostaining in Urothelial Carcinoma of the Urinary Bladder Is Associated with Invasiveness and Poor Prognosis.

Authors:  Basim Al-Maghrabi; Wafaey Gomaa; Mohammed Abdelwahed; Jaudah Al-Maghrabi
Journal:  Anal Cell Pathol (Amst)       Date:  2019-04-21       Impact factor: 2.916

5.  Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-03-20       Impact factor: 7.012

Review 6.  Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.

Authors:  Vinit Kumar; Dmitry I Gabrilovich
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

Review 7.  Inflammatory pathways as promising targets to increase chemotherapy response in bladder cancer.

Authors:  Zhaowei Zhu; Zhoujun Shen; Chen Xu
Journal:  Mediators Inflamm       Date:  2012-07-02       Impact factor: 4.711

8.  Cyclooxygenase-2 in tumor-associated macrophages promotes breast cancer cell survival by triggering a positive-feedback loop between macrophages and cancer cells.

Authors:  Hongzhong Li; Bing Yang; Jing Huang; Yong Lin; Tingxiu Xiang; Jingyuan Wan; Hongyuan Li; Salem Chouaib; Guosheng Ren
Journal:  Oncotarget       Date:  2015-10-06

9.  Identification of Epigenetic Interactions between miRNA and Gene Expression as Potential Prognostic Markers in Bladder Cancer.

Authors:  Amira Awadalla; Hassan Abol-Enein; Eman T Hamam; Asmaa E Ahmed; Salma M Khirallah; Ahmed El-Assmy; Sally Abdallah Mostafa; Ahmed O Babalghith; Mohamed Ali; Mona Abdel-Rahim; Ahmed A Shokeir; Ahmed M Harraz
Journal:  Genes (Basel)       Date:  2022-09-10       Impact factor: 4.141

10.  Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy.

Authors:  P J Boström; J Thoms; J Sykes; O Ahmed; A Evans; B W G van Rhijn; T Mirtti; O Stakhovskyi; M Laato; D Margel; M Pintilie; C Kuk; M Milosevic; A R Zlotta; R G Bristow
Journal:  Bladder Cancer       Date:  2016-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.